Inicio › Cáncer de riñón (carcinoma de células renales) › Nueva Jersey
Ensayos clínicos de Cáncer de riñón (carcinoma de células renales) en Nueva Jersey
17 estudios sobre Cáncer de riñón (carcinoma de células renales) buscan participantes en Nueva Jersey.
Ciudades en Nueva Jersey
Texto oficial del estudio (inglés)
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
- Atlantic Health System Morristown Medical Center ( Site 0109), Morristown
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 oct 2026 · NCT07489495Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 oct 2026 · NCT03866382Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Englewood Hospital and Medical Center, Englewood
- Hackettstown Medical Center, Hackettstown
- Morristown Medical Center, Morristown
- y 6 más
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 a 75 · Todos los sexos · Actualizado el 2 oct 2026 · NCT05334069A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- START New Jersey, East Brunswick
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT06270706Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #88, East Brunswick
- Exelixis Clinical Site #105, Hackensack
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT05176483Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Cooper Hospital University Medical Center, Camden
- Memorial Sloan Kettering Monmouth, Middletown
- y 2 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 sept 2026 · NCT05327686Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- MSK Basking Ridge, Basking Ridge
- MSK Monmouth, Middletown
- MSK Bergen, Montvale
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT07227415ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Astera Cancer Care, East Brunswick
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 sept 2026 · NCT05059444A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT05837767Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Jefferson Cherry Hill Hospital, Cherry Hill
- Hackensack University Medical Center, Hackensack
- y 7 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT06661720A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- John Theurer Cancer Center, Hackensack
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT04895709Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Xencor Investigative Site, New Brunswick
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 ago 2026 · NCT05433142A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 jul 2026 · NCT06764771A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 jun 2026 · NCT06835972KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Rutgers Cancer Institute of New Jersey, New Brunswick
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 jun 2026 · NCT06026410A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activites), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 mar 2026 · NCT06699602Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
- Hackensack University Medical Center, Hackensack
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2025 · NCT04510597De ClinicalTrials.gov, datos obtenidos el 7 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.